Medical Subject Headings

Last uploaded: March 22, 2026

Id	http://purl.bioontology.org/ontology/MESH/C000613593 http://purl.bioontology.org/ontology/MESH/C000613593
Preferred Name	durvalumab
Synonyms	MEDI4736 Imfinzi MEDI-4736
Type	http://www.w3.org/2002/07/owl#Class

altLabel	MEDI4736 Imfinzi MEDI-4736
prefLabel	durvalumab
Scope Statement	an IgG1 that targets programmed cell death 1 ligand 1 (PD-L1); enhances the immune response to tumor cells and is used for the treatment of locally advanced or metastatic urothelial carcinoma
type	http://www.w3.org/2002/07/owl#Class
isa	http://purl.bioontology.org/ontology/MESH/D000074322
PA	D000074322
tui	T116 T129 T121
HM	D000911
SC	1
TERMUI	T000942542 T000942541 T000884078 T000914468
TH	FDA SRS (2017) NLM (2015) USAN (19XX) INN (19XX) NLM (2017)
SRC	Lancet Oncol. 2016 Mar;17(3):299-308.
MMR	20191031
notation	C000613593
Semantic type UMLS property	http://purl.bioontology.org/ontology/STY/T129 http://purl.bioontology.org/ontology/STY/T121 http://purl.bioontology.org/ontology/STY/T116
cui	C4055109 C4473954 C3641122
MeSH Frequency	513
LT	TRD
DSC	20170122
Inverse of RB	28X28X9OKV 0
Mapped to	http://purl.bioontology.org/ontology/MESH/D000911
MDA	20170122

Delete	Subject	Author	Type	Created
No notes to display